logo

North America Pharmaceutical Plastic Bottles Market Size (2024 - 2029)

The North America Pharmaceutical Plastic Bottles Market is experiencing growth driven by the increasing emphasis on innovative packaging solutions that help pharmaceutical brands differentiate themselves. Compliance with stringent regulations, such as the FDA's Current Good Manufacturing Practices, is crucial for ensuring the safety and integrity of pharmaceutical products, thereby boosting the demand for specialized plastic bottle packaging. The market is also influenced by the rising demand for tamper-evident packaging in pharmaceutical applications. However, the market faces challenges due to the upward trend in plastic prices, which are closely linked to fluctuations in crude oil and natural gas costs.

Home Market Analysis Packaging Research Packaging Materials Research North America Pharmaceutical Plastic Bottles Market Market Size

Market Size of North America Pharmaceutical Plastic Bottles Industry

North America Pharmaceutical Plastic Bottles Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 2.69 Billion
Market Size (2029) USD 3.09 Billion
CAGR (2024 - 2029) 2.81 %
Market Concentration Low

Major Players

North America Pharmaceutical Plastic Bottles Market Major Players

*Disclaimer: Major Players sorted in no particular order

North America Pharmaceutical Plastic Bottles Market Analysis

The North America Pharmaceutical Plastic Bottles Market size is estimated at USD 2.69 billion in 2024, and is expected to reach USD 3.09 billion by 2029, growing at a CAGR of 2.81% during the forecast period (2024-2029).

  • The increasing importance of contemporary packaging in the pharmaceutical industry has enabled brands to capitalize on the advantages of unique plastic bottle packaging design to differentiate themselves from their competitors and boost their bottom line.
  • The US Food and Drug Administration (FDA) has established strict requirements to ensure that pharmaceutical products are safe. Thus, plastic bottle materials must comply with regulations like the FDA’s Current Good Manufacturing Practices (cGMP). These regulations cover aspects like the selection of materials, manufacturing processes, and packaging controls, all of which impact the safety and integrity of pharmaceutical products. Compliance with these regulations drives the demand for specialized plastic bottle packaging products for pharmaceutical applications to meet the standards.
  • Vendors offer a complete bundle solution to help clients exploit the growing demand for tamper-evident (TE) packaging in the pharmaceutical syrup and liquid medicine market. In March 2023, pharma film coatings and specialty excipients leader Colorcon Inc. announced the acquisition of Airnov Healthcare Pack, a player in pharmaceutical film coatings. The Airnov portfolio includes specialized plastic bottles containing oxygen barrier materials, quality drop-in products such as canisters and packets, and integrated desiccant systems.
  • Despite undeniable advances in the industry, there is an upward price trend for plastics. The primary raw materials used in plastic manufacturing are crude oil and natural gas. As a result, the cost of plastic materials and resin rises when the price of oil or gas increases as producers pass through these fluctuations to purchasers.​ In particular, recent years have seen significant calls for intervention against high pharmaceutical plastic bottle and packaging prices.

North America Pharmaceutical Plastic Bottles Industry Segmentation

Pharmaceutical plastic bottles are containers specifically designed and manufactured for the storage and distribution of pharmaceutical products. These bottles are an essential component of the pharmaceutical packaging industry and play a crucial role in maintaining the safety, efficacy, and integrity of medications and other healthcare products.

The North American pharmaceutical plastic bottles market is segmented by raw material (polyethylene terephthalate (PET), polypropylene (PP), low-density polyethylene (LDPE), and high-density polyethylene (HDPE)), type (dropper bottles, nasal spray bottles, liquid bottles, oral care, and other types), and country (United States and Canada). The report offers market sizes and forecasts in terms of value (USD) for all the above segments.

By Raw Material
Polyethylene Terephthalate (PET)
Polypropylene (PP)
Low-density Polyethylene (LDPE)
High-density Polyethylene (HDPE)
By Type
Dropper Bottles
Nasal Spray Bottles
Liquid Bottles
Oral Care
Other Types
By Country
United States
Canada
Need A Different Region Or Segment?
Customize Now

North America Pharmaceutical Plastic Bottles Market Size Summary

The North American pharmaceutical plastic bottles market is experiencing steady growth, driven by the increasing demand for innovative packaging solutions in the pharmaceutical industry. The market is characterized by the adoption of unique plastic bottle designs that help brands differentiate themselves and enhance their market presence. Compliance with stringent regulations set by the US Food and Drug Administration, such as the Current Good Manufacturing Practices, is crucial for ensuring the safety and integrity of pharmaceutical products. This regulatory landscape fosters the demand for specialized plastic bottle packaging that meets these standards. The market is also witnessing a rise in the demand for tamper-evident packaging solutions, particularly in the pharmaceutical syrup and liquid medicine sectors, as companies like Colorcon Inc. expand their offerings through strategic acquisitions.

The market's growth is further supported by the increasing prevalence of chronic diseases in North America, leading to a higher demand for solid containers and plastic bottles for long-term medication. High-density polyethylene (HDPE) is a preferred material due to its moisture barrier properties and resistance to solvents, acids, and alkalis, making it suitable for pharmaceutical packaging. The market is fragmented, with key players such as Amcor Group, Berry Global, and ALPLA Werke actively engaging in mergers, acquisitions, and product innovations to strengthen their market positions. Recent developments, such as Amcor's expansion of thermoforming capabilities and the introduction of sustainable packaging solutions, highlight the industry's focus on sustainability and regulatory compliance. As healthcare spending continues to rise, the demand for cost-effective and versatile packaging solutions, like plastic bottles, is expected to grow, further driving the market's expansion.

Explore More

North America Pharmaceutical Plastic Bottles Market Size - Table of Contents

  1. 1. MARKET INSIGHTS

    1. 1.1 Market Overview

    2. 1.2 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.2.1 Threat of New Entrants

      2. 1.2.2 Bargaining Power of Buyer

      3. 1.2.3 Bargaining Power of Suppliers

      4. 1.2.4 Threat of Substitute Products

      5. 1.2.5 Intensity of Competitive Rivalry

    3. 1.3 Industry Value Chain Analysis

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Raw Material

      1. 2.1.1 Polyethylene Terephthalate (PET)

      2. 2.1.2 Polypropylene (PP)

      3. 2.1.3 Low-density Polyethylene (LDPE)

      4. 2.1.4 High-density Polyethylene (HDPE)

    2. 2.2 By Type

      1. 2.2.1 Dropper Bottles

      2. 2.2.2 Nasal Spray Bottles

      3. 2.2.3 Liquid Bottles

      4. 2.2.4 Oral Care

      5. 2.2.5 Other Types

    3. 2.3 By Country

      1. 2.3.1 United States

      2. 2.3.2 Canada

North America Pharmaceutical Plastic Bottles Market Size FAQs

The North America Pharmaceutical Plastic Bottles Market size is expected to reach USD 2.69 billion in 2024 and grow at a CAGR of 2.81% to reach USD 3.09 billion by 2029.

In 2024, the North America Pharmaceutical Plastic Bottles Market size is expected to reach USD 2.69 billion.

North America Pharmaceutical Plastic Bottles Market Report Snapshots

North America Pharmaceutical Plastic Bottles Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)